| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 71 |
| 1 | METFORMIN | 48 |
| 2 | THIAMINE HYDROCHLORIDE | 35 |
| 3 | METRONIDAZOLE | 31 |
| 4 | METRONIDAZOLE TOPICAL | 31 |
| 5 | METFORMIN ER 500 MG | 30 |
| 6 | METFORMIN ER 750 MG | 30 |
| 7 | FLUOROURACIL | 22 |
| 8 | FLUOROURACIL CREAM, 0.5% | 21 |
| 9 | PANTOPRAZOLE | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FEDRATINIB HYDROCHLORIDE | 6 | 0.0044 |
| 1 | HYALURONATE SODIUM | 4 | 0.0026 |
| 2 | SENNOSIDES A AND B | 3 | 0.0018 |
| 3 | HYDROXOCOBALAMIN | 7 | 0.0017 |
| 4 | HYDROCORTISONE VALERATE | 1 | 0.0016 |
| 5 | BRODALUMAB | 3 | 0.0015 |
| 6 | CLINDAMYCIN PHOSPHATE | 8 | 0.0014 |
| 7 | ERTAPENEM SODIUM | 9 | 0.0012 |
| 8 | CHLORPROMAZINE HYDROCHLORIDE | 1 | 0.0010 |
| 9 | UREA | 2 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 72 |
| 1 | Proton Pump Inhibitor [EPC] | 35 |
| 2 | Nitroimidazole Antimicrobial [EPC] | 31 |
| 3 | Corticosteroid [EPC] | 30 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 5 | Platinum-based Drug [EPC] | 24 |
| 6 | Benzodiazepine [EPC] | 23 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 23 |
| 8 | Calcium Channel Blocker [EPC] | 20 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 3 | 0.0015 |
| 1 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 4 | 0.0006 |
| 3 | Catechol-O-Methyltransferase Inhibitor [EPC] | 3 | 0.0006 |
| 4 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 5 | 0.0005 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 31 | 0.0005 |
| 8 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 9 | Aluminum Complex [EPC] | 10 | 0.0004 |